A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol
A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol
Recruiting · NCT06381739 · Registry updated 2026-01-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of a Next Generation COVID-19 Vaccine Delivered by Inhaled Aerosol | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 2 | 2026-01-26 | NCT06381739 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Institutes of Health Research (CIHR) | 339 |
| McMaster University | 202 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Canadian Center for Vaccinology, Dalhousie University | Halifax | Canada | 1 |
| Health Sciences Centre | Hamilton | Canada | 1 |